Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients

International Journal of Cancer

Volumn 131, Issue 4, 2012, Pages 864-873

  Ålgars, Annika ^a,b   Irjala, Heikki ^a,b   Vaittinen, Samuli ^a,c   Huhtinen, Heikki ^a   Sundström, Jari ^a,c   Salmi, Marko ^b,c   Ristamäki, Raija ^a   Jalkanen, Sirpa ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

CLEVER 1; colorectal cancer; lymphatic vessels; macrophages; Podoplanin; Stabilin 1

Indexed keywords

CD68 ANTIGEN; COMMON LYMPHATIC AND VASCULAR ENDOTHELIAL RECEPTOR 1; MANNOSE RECEPTOR; PODOPLANIN; STABILIN 1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CD3+ T LYMPHOCYTE; CELL COUNT; CELL DENSITY; CELL FUNCTION; CELL INFILTRATION; CELL TYPE; CELLULAR DISTRIBUTION; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE LYMPH; LYMPH VESSEL; LYMPHANGIOGENESIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PERITUMORAL MACROPHAGE; PRIORITY JOURNAL; REGULATORY MACROPHAGE; SUPPRESSOR CELL; SURVIVAL PREDICTION; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; CELL ADHESION MOLECULES, NEURONAL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC VESSELS; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; RECEPTORS, LYMPHOCYTE HOMING; SURVIVAL ANALYSIS;

EID: 84862556278     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26457     Document Type: Article

References (41)

1. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420: 860-7. (Pubitemid 36019639)
2. Mantovani A, Allavena P, Sica A, Balkwill F,. Cancer-related inflammation. Nature 2008; 454: 436-44.
3. Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A,. Pathways connecting inflammation and cancer. Curr Opin Genet Dev 2008; 18: 3-10. (Pubitemid 351694444)
4. Mantovani A,. Cancer: inflaming metastasis. Nature 2009; 457: 36-7.
5. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
6. Mantovani A, Sica A,. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 2010; 22: 231-7.
7. Sica A, Allavena P, Mantovani A,. Cancer related inflammation: the macrophage connection. Cancer Lett 2008; 267: 204-15.
8. Lund AW, Swartz MA,. Role of lymphatic vessels in tumor immunity: passive conduits or active participants? J Mammary Gland Biol Neoplasia 2010; 15: 341-52.
9. Goerdt S, Politz O, Schledzewski K, Birk R, Gratchev A, Guillot P, Hakiy N, Klemke CD, Dippel E, Kodelja V, Orfanos CE,. Alternative versus classical activation of macrophages. Pathobiology 1999; 67: 222-6. (Pubitemid 30135909)
10. Allavena P, Sica A, Garlanda C, Mantovani A,. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 2008; 222: 155-61. (Pubitemid 351430369)
11. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A,. Macrophage polarization in tumour progression. Semin Cancer Biol 2008; 18: 349-55.
12. Lackner C, Jukic Z, Tsybrovskyy O, Jatzko G, Wette V, Hoefler G, Klimpfinger M, Denk H, Zatloukal K,. Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer. Virchows Arch 2004; 445: 160-7. (Pubitemid 39215547)
13. Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R,. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007; 13: 1472-9. (Pubitemid 46450437)
14. Zhou Q, Peng RQ, Wu XJ, Xia Q, Hou JH, Ding Y, Zhou QM, Zhang X, Pang ZZ, Wan DS, Zeng YX, Zhang XS,. The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med 2010; 8: 13.
15. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D,. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999; 154: 385-94. (Pubitemid 29094089)
16. Wicki A, Christofori G,. The potential role of podoplanin in tumour invasion. Br J Cancer 2007; 96: 1-5. (Pubitemid 46094630)
17. Achen MG, McColl BK, Stacker SA,. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005; 7: 121-7. (Pubitemid 40248338)
18. Parr C, Jiang WG,. Quantitative analysis of lymphangiogenic markers in human colorectal cancer. Int J Oncol 2003; 23: 533-9.
19. Omachi T, Kawai Y, Mizuno R, Nomiyama T, Miyagawa S, Ohhashi T, Nakayama J,. Immunohistochemical demonstration of proliferating lymphatic vessels in colorectal carcinoma and its clinicopathological significance. Cancer Lett 2007; 246: 167-72. (Pubitemid 44959388)
20. Lu Y, Yang Q, Du Y, Feng G, Yang C,. Expression analysis of lymphangiogenic factors in human colorectal cancer with quantitative RT-PCR. Cancer Invest 2007; 25: 393-6. (Pubitemid 47450670)
21. Sundlisaeter E, Rosland GV, Hertel JK, Sakariassen PO, Almas B, Dicko A, Sondenaa K,. Increased lymphatic vascular density is seen before colorectal cancers reach stage II and growth factor FGF-2 is downregulated in tumor tissue compared with normal mucosa. APMIS 2009; 117: 212-21.
22. Matsumoto K, Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Shibao K, Tsurudome Y, Hirata K, Nagata N, Itoh H,. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis Colon Rectum 2007; 50: 308-14. (Pubitemid 46393971)
23. Irjala H, Elima K, Johansson EL, Merinen M, Kontula K, Alanen K, Grenman R, Salmi M, Jalkanen S,. The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels. Eur J Immunol 2003; 33: 815-24. (Pubitemid 36367685)
24. Salmi M, Koskinen K, Henttinen T, Elima K, Jalkanen S,. CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood 2004; 104: 3849-57. (Pubitemid 39620128)
25. Kzhyshkowska J, Gratchev A, Goerdt S,. Stabilin-1, a homeostatic scavenger receptor with multiple functions. J Cell Mol Med 2006; 10: 635-49. (Pubitemid 44874274)
26. Goerdt S, Bhardwaj R, Sorg C,. Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am J Pathol 1993; 142: 1409-22. (Pubitemid 24058128)
27. Politz O, Gratchev A, McCourt PA, Schledzewski K, Guillot P, Johansson S, Svineng G, Franke P, Kannicht C, Kzhyshkowska J, Longati P, Velten FW, et al. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002; 362: 155-64. (Pubitemid 34174473)
28. Liang P, Hong JW, Ubukata H, Liu HR, Watanabe Y, Katano M, Motohashi G, Kasuga T, Nakada I, Tabuchi T,. Increased density and diameter of lymphatic microvessels correlate with lymph node metastasis in early stage invasive colorectal carcinoma. Virchows Arch 2006; 448: 570-5. (Pubitemid 44490554)
29. Liang P, Nakada I, Hong JW, Tabuchi T, Motohashi G, Takemura A, Nakachi T, Kasuga T,. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis. Ann Surg Oncol 2007; 14: 470-7. (Pubitemid 46175291)
30. Irjala H, Alanen K, Grenman R, Heikkila P, Joensuu H, Jalkanen S,. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res 2003; 63: 4671-6. (Pubitemid 36951046)
31. Maula SM, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamaki R,. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003; 63: 1920-6. (Pubitemid 36460859)
32. Nakamura Y, Yasuoka H, Tsujimoto M, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K,. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat 2005; 91: 125-32. (Pubitemid 40684925)
33. Straume O, Jackson DG, Akslen LA,. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003; 9: 250-6. (Pubitemid 36109741)
34. Dadras SS, Paul T, Bertoncini J, Brown LF, Muzikansky A, Jackson DG, Ellwanger U, Garbe C, Mihm MC, Detmar M,. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003; 162: 1951-60. (Pubitemid 36613052)
35. Hall FT, Freeman JL, Asa SL, Jackson DG, Beasley NJ,. Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129: 716-9. (Pubitemid 36858956)
36. Yasuoka H, Nakamura Y, Zuo H, Tang W, Takamura Y, Miyauchi A, Nakamura M, Mori I, Kakudo K,. VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma. Mod Pathol 2005; 18: 1127-33. (Pubitemid 41224505)
37. Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S,. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma. Oncology 2009; 77: 53-62.
38. Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B,. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 2009; 27: 186-92.
39. Savage ND, de Boer T, Walburg KV, Joosten SA, van Meijgaarden K, Geluk A, Ottenhoff TH,. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J Immunol 2008; 181: 2220-6.
40. Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A, Sica A,. Cellular and molecular pathways linking inflammation and cancer. Immunobiology 2009; 214: 761-77.
41. Movahedi K, Laoui D, Gysemans C, Baeten M, Stange G, Van den Bossche J, Mack M, Pipeleers D, In't Veld P, De Baetselier P, Van Ginderachter JA,. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 2010; 70: 5728-39.